Matches in Wikidata for { <http://www.wikidata.org/entity/Q68501530> ?p ?o ?g. }
Showing items 1 to 48 of
48
with 100 items per page.
- Q68501530 description "artikull shkencor i botuar më 01 janar 1988" @default.
- Q68501530 description "artículu científicu espublizáu en xineru de 1988" @default.
- Q68501530 description "im Januar 1988 veröffentlichter wissenschaftlicher Artikel" @default.
- Q68501530 description "scientific article published on 01 January 1988" @default.
- Q68501530 description "wetenschappelijk artikel" @default.
- Q68501530 description "наукова стаття, опублікована в січні 1988" @default.
- Q68501530 name "Prednimustine, methotrexate, 5-fluorouracil, mitoxantrone and tamoxifen for advanced breast cancer in postmenopausal women. A phase II trial" @default.
- Q68501530 name "Prednimustine, methotrexate, 5-fluorouracil, mitoxantrone and tamoxifen for advanced breast cancer in postmenopausal women. A phase II trial" @default.
- Q68501530 name "Prednimustine, methotrexate, 5-fluorouracil, mitoxantrone and tamoxifen for advanced breast cancer in postmenopausal women. A phase II trial" @default.
- Q68501530 type Item @default.
- Q68501530 label "Prednimustine, methotrexate, 5-fluorouracil, mitoxantrone and tamoxifen for advanced breast cancer in postmenopausal women. A phase II trial" @default.
- Q68501530 label "Prednimustine, methotrexate, 5-fluorouracil, mitoxantrone and tamoxifen for advanced breast cancer in postmenopausal women. A phase II trial" @default.
- Q68501530 label "Prednimustine, methotrexate, 5-fluorouracil, mitoxantrone and tamoxifen for advanced breast cancer in postmenopausal women. A phase II trial" @default.
- Q68501530 prefLabel "Prednimustine, methotrexate, 5-fluorouracil, mitoxantrone and tamoxifen for advanced breast cancer in postmenopausal women. A phase II trial" @default.
- Q68501530 prefLabel "Prednimustine, methotrexate, 5-fluorouracil, mitoxantrone and tamoxifen for advanced breast cancer in postmenopausal women. A phase II trial" @default.
- Q68501530 prefLabel "Prednimustine, methotrexate, 5-fluorouracil, mitoxantrone and tamoxifen for advanced breast cancer in postmenopausal women. A phase II trial" @default.
- Q68501530 P1433 Q68501530-6B114AD5-77AA-4AB6-A81E-3912618BEF36 @default.
- Q68501530 P1476 Q68501530-B04F19A3-08C7-4CDA-B815-5F881F207F94 @default.
- Q68501530 P2093 Q68501530-B68B2C73-3F10-419E-B179-3199EDD263E4 @default.
- Q68501530 P2093 Q68501530-CBB512C7-05E7-49A9-A43D-E4379B7F23EC @default.
- Q68501530 P304 Q68501530-4C93BD59-2A78-406D-99A2-9C19D1A9B0BB @default.
- Q68501530 P31 Q68501530-C157D606-5BB6-4A40-ACEA-7FA426ADBC7C @default.
- Q68501530 P356 Q68501530-83A0737F-1AB0-4CEC-96BD-212D335ED6DD @default.
- Q68501530 P433 Q68501530-3BBAB9A7-293D-4A98-BC42-E3C4062E4ABB @default.
- Q68501530 P478 Q68501530-B399B768-EB61-4F07-8690-870018ABAFB6 @default.
- Q68501530 P577 Q68501530-1AE316F1-3701-404E-8221-0752DEC2FC76 @default.
- Q68501530 P698 Q68501530-D4930C22-855B-41CF-AAB7-0EFFA568CC08 @default.
- Q68501530 P921 Q68501530-0AE13455-5639-4FF0-811F-EDAF2F60BE53 @default.
- Q68501530 P921 Q68501530-83D78606-1860-4A68-AC98-13A7B8F4718D @default.
- Q68501530 P921 Q68501530-8AAE0F45-1629-4B6B-B38C-3F231787E1F7 @default.
- Q68501530 P921 Q68501530-E6D3D568-D49A-4FAC-9DD8-BF175BE9AA6B @default.
- Q68501530 P356 02841868809093531 @default.
- Q68501530 P698 3415852 @default.
- Q68501530 P1433 Q326164 @default.
- Q68501530 P1476 "Prednimustine, methotrexate, 5-fluorouracil, mitoxantrone and tamoxifen for advanced breast cancer in postmenopausal women. A phase II trial" @default.
- Q68501530 P2093 "H T Mouridsen" @default.
- Q68501530 P2093 "M Andersson" @default.
- Q68501530 P304 "235-239" @default.
- Q68501530 P31 Q13442814 @default.
- Q68501530 P356 "10.3109/02841868809093531" @default.
- Q68501530 P433 "3" @default.
- Q68501530 P478 "27" @default.
- Q68501530 P577 "1988-01-01T00:00:00Z" @default.
- Q68501530 P698 "3415852" @default.
- Q68501530 P921 Q238512 @default.
- Q68501530 P921 Q412178 @default.
- Q68501530 P921 Q422232 @default.
- Q68501530 P921 Q42824440 @default.